Copyright
©The Author(s) 2024.
World J Orthop. Feb 18, 2024; 15(2): 118-128
Published online Feb 18, 2024. doi: 10.5312/wjo.v15.i2.118
Published online Feb 18, 2024. doi: 10.5312/wjo.v15.i2.118
Table 1 Patient demographics
Knees (n = 255) | |
Sex, n (%) | |
Male | 88 (34.5) |
Female | 167 (65.5) |
Age (yr) [range] | 60.6 [32-83] |
Race, n (%) | |
White | 112 (43.9) |
African American | 63 (24.7) |
Asian | 10 (3.9) |
Other | 70 (27.5) |
Smoking status, n (%) | |
Current | 14 (5.5) |
Former | 92 (36.1) |
Never | 149 (58.4) |
Insurance status, n (%) | |
Medicare | 79 (31.0) |
Medicaid | 32 (12.5) |
Commercial | 144 (56.5) |
ASA score, n (%) | |
1 | 4 (1.6) |
2 | 148 (58.0) |
3 | 102 (40.0) |
4 | 1 (0.4) |
BMI (kg/m2) [range] | 33.5 [16.8-57.8] |
CCI | 3.0 ± 2.2 |
Primary diagnosis, n (%) | |
Primary OA | 247 (96.9) |
Post-Traumatic OA | 7 (2.7) |
AVN | 1 (0.4) |
Table 2 Intraoperative and implant variables
Knees (n = 255) | |
Operative time (min) [range] | 105.3 [65-237] |
Liner, n (%) | |
Standard | 213 (83.5) |
Deep dish | 42 (16.5) |
Anesthesia, n (%) | |
General | 21 (8.2) |
Spinal/Regional/Block | 234 (91.8) |
Bearing surface, n (%) | |
Oxidized Zirconium-on-Polyethylene | 57 (22.4) |
Cobalt Chrome-on-Polyethylene | 198 (77.6) |
Technology, n (%) | |
Manual | 158 (62.0) |
Computer navigation | 88 (34.5) |
Robotic assistance | 9 (3.5) |
Table 3 Short-term clinical outcomes
Knees (n = 255) | |
LOS (days) [range] | 2.1 [0.3-19.5] |
Time to follow-up (years) [range] | 3.3 [2.1-6.6] |
Discharge disposition, n (%) | |
Home | 236 (92.5) |
SNF | 16 (6.3) |
ARF | 3 (1.2) |
90-d ED visits, n (%) | 18 (7.1) |
Non-orthopedic related | 6 (2.4) |
Orthopedic related | 12 (4.7) |
Knee pain and swelling | 6 |
Knee pain and erythema | 1 |
Calf pain and lightheadedness | 1 |
Groin pain | 1 |
VTE | 1 |
NSAID poisoning | 1 |
Opioid poisoning | 1 |
90-d readmissions, n (%) | 3 (1.2) |
PJI | 1 |
AKI | 1 |
Gastric bleed due to NSAID poisoning | 1 |
Table 4 Long-term clinical outcomes
Knees (n = 255) | Mean time to revision (years) [range] | |
Revisions, n (%) | 4 (1.6) | 1.1 [0.7-1.5] |
Arthrofibrosis | 2 | 1.3 [1.1-1.5] |
Aseptic femoral loosening | 1 | 1.1 |
PJI | 1 | 0.7 |
Table 5 Subanalysis: Survivorship by bearing surface material
Cobalt chrome (n = 198) | Oxidized zirconium (n = 57) | |
Revisions, n (%) | 4 (2.0) | 0 (0) |
Arthrofibrosis | 2 | 0 |
Aseptic femoral loosening | 1 | 0 |
PJI | 1 | 0 |
Table 6 Subanalysis: Survivorship by liner type
Standard (n = 213) | Deep dish (n = 42) | |
Revisions, n (%) | 3 (1.4) | 1 (2.4) |
Arthrofibrosis | 1 | 1 |
Aseptic femoral loosening | 1 | 0 |
PJI | 1 | 0 |
Table 7 Patient reported outcome measures (mean ± SD)
Knees (n = 255) | P value | |
KOOS JR | ||
Preoperative | 43.3 (13.0) | |
6 mo | 56.5 (16.1) | |
2 yr | 62.2 (13.9) | |
Δ Preop to 6 mo | 13.2 (16.4) | < 0.0001 |
Δ Preop to 2 yr | 18.9 (16.9) | < 0.0001 |
PROMIS pain intensity | ||
Preoperative | 55.6 (6.9) | |
6 mo | 50.1 (8.1) | |
2 yr | 48.6 (7.6) | |
Δ Preop to 6 mo | -5.5 (8.2) | < 0.0001 |
Δ Preop to 2 yr | -7.0 (6.7) | < 0.0001 |
PROMIS pain interference | ||
Preoperative | 65.3 (5.7) | |
6 mo | 61.4 (8.0) | |
2 yr | 59.5 (8.0) | |
Δ Preop to 6 mo | -3.9 (7.5) | < 0.0001 |
Δ Preop to 2 yr | -5.8 (6.3) | < 0.0001 |
PROMIS mobility | ||
Preoperative | 35.5 (4.1) | |
6 mo | 38.1 (4.3) | |
2 yr | 40.3 (5.6) | |
Δ Preop to 6 mo | 2.6 (4.8) | < 0.0001 |
Δ Preop to 2 yr | 4.8 (3.5) | < 0.0001 |
PROMIS physical health | ||
Preoperative | 39.5 (7.3) | |
6 mo | 41.8 (6.9) | |
2 yr | 42.0 (6.1) | |
Δ Preop to 6 mo | 2.3 (6.6) | 0.029 |
Δ Preop to 2 yr | 2.5 (5.4) | 0.045 |
- Citation: Katzman JL, Habibi AA, Haider MA, Cardillo C, Fernandez-Madrid I, Meftah M, Schwarzkopf R. Mid-term outcomes of a kinematically designed cruciate retaining total knee arthroplasty. World J Orthop 2024; 15(2): 118-128
- URL: https://www.wjgnet.com/2218-5836/full/v15/i2/118.htm
- DOI: https://dx.doi.org/10.5312/wjo.v15.i2.118